| Application no. and date | 19192230.1 (espacenet) (Federated) (European Patent Register), 20161117 | | Patent/reg. no. and date | DK/EP 3639811, 20240320 | | Publication date | 20200422 | | Priority no. and date | EP 15194864, 20151117 | | EP pub. no. and date |
EP 3639811 20200422 | | Effective date | | | Applicant/owner | Highlight Therapeutics, S.L., Parque Cientifico de la Universidad de Valencia,
C/ Catedrático Agustin Escardino 9, Paterna,
46980 Valencia, ES | | Applicant ref. no. | | | Inventor | VILLANUEVA GARCÃ?A, Ana, Plaza Xuquer 8-8
46021 Valencia, ES,
POZUELO RUBIO, Mercedes,
46980 Paterna Valencia, ES,
QUINTERO ORTIZ, Marisol,
46980 Paterna Valencia, ES | | Representative | | | Opponent | | | IPC Class | A61K 31/713 (2006.01) , A61K 47/26 (2006.01) , A61K 47/69 (2017.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) , A61P 35/00 (2006.01) | | Title | NOVEL PHARMACEUTICAL COMPOSITION COMPRISING PARTICLES COMPRISING A COMPLEX OF A DOUBLE-STRANDED POLYRIBONUCLEOTIDE AND A POLYALKYLENEIMINE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
